Evidence map›Paper›PMID 24239664›Full record

SynthesisJournal of the American College of Cardiology2014

Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.

Yoav Ben-Shlomo, Melissa Spears, Chris Boustred, Margaret May, Simon G Anderson, Emelia J Benjamin, Pierre Boutouyrie, James Cameron, Chen-Huan Chen, J Kennedy Cruickshank and 21 more

4 registry-linked trialsOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 876 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
876citing papers in PubMed, 14 pooled it
67.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03109795 phase4terminatednot on this mapstarted 2017, after this paper: background citation

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

TypeinterventionalSponsorUniversity of IowaRan2017 to 2023Enrolled35ConditionsAnxiety, HypertensionArmsClonidine Pill, Hydrochlorothiazide
NCT03570216 nacompletednot on this mapstarted 2019, after this paper: background citation

Acute Effects of High-Intensity Interval Exercise vs. Moderate-Intensity Continuous Exercise on Arterial Stiffness in Chronic Stroke

TypeinterventionalSponsorMcMaster UniversityRan2019 to 2020Enrolled4ConditionsStroke, CardiovascularArmsCardiopulmonary exercise test, Moderate-intensity continuous exercise, High-intensity interval exercise
NCT03659695 naterminatednot on this mapstarted 2020, after this paper: background citation

Cardioprotective Effects of Freeze Dried Grape Powder Supplementation on Blood Pressure and Plasma Lipids/Lipoproteins: A Pilot Study

TypeinterventionalSponsorUniversity of ArizonaRan2020 to 2024Enrolled16ConditionsCardiovascular Risk FactorArmsGrape Powder, Placebo Powder
NCT06836622 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Correlation Between the Values of Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity

TypeobservationalSponsorHospital de BaseRan2026 to 2027Enrolled350ConditionsHypertension, Arterial Stiffness, Pulse Wave Analysis, Pulse Wave Velocity
3 · Its place in the literature

Who cites it

876 citing papers in PubMed, 14 syntheses or guidelines pooled it, 1,767 citations in OpenAlex.

  1. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Guideline
  15. Trial
  16. Trial
  17. Resistance training and subcortical vascular cognitive impairment: A 12-month randomized trial.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Trial
  18. Intradialytic Exercise: Effects on Arterial Stiffness and Gait Speed in Patients Undergoing Hemodialysis.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Trial
  19. Trial
  20. Trial

816 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 19 institutions in 9 countries.

Yoav Ben-ShlomoSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. Electronic address: y.ben-shlomo@bristol.ac.uk.
Melissa SpearsSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Chris BoustredSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Margaret MaySchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Simon G AndersonInstitute of Cardiovascular Sciences, University of Manchester, United Kingdom.
Emelia J BenjaminNational Heart Lung and Blood Institute and Boston University's Framingham Heart Study, Cardiology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Pierre BoutouyrieINSERM U 970, Paris-Descartes University, Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
James CameronMonash Cardiovascular Research Centre, MonashHEART and Monash University Department of Medicine (MMC), Melbourne, Australia.
Chen-Huan ChenSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
J Kennedy CruickshankKing's College & King's Health Partners, St. Thomas' & Guy's Hospital, London, United Kingdom.
Shih-Jen HwangBranch of Population Sciences, Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, Maryland.
Edward G LakattaLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Stephane LaurentINSERM U 970, Paris-Descartes University, Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
João MaldonadoInstituto de Investigação e Formação Cardiovascular, Penacova, Portugal.
Gary F MitchellCardiovascular Engineering, Inc., Norwood, Massachusetts.
Samer S NajjarLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland; MedStar Heart Research Institute, Washington, DC.
Anne B NewmanCenter for Aging and Population Health, Pittsburgh, Pennsylvania.
Mitsuru OhishiDepartment of Geriatric Medicine, Osaka University, Osaka, Japan.
Bruno PannierCentre d'Investigations Preventives et Cliniques, Paris, France.
Telmo PereiraEscola Superior de Tecnologia da Saúde de Coimbra, Coimbra, Portugal.
Ramachandran S VasanNational Heart Lung and Blood Institute and Boston University's Framingham Heart Study, Department of Medicine, Boston University, Boston, Massachusetts.
Tomoki ShokawaDepartment of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Kim Sutton-TyrellCenter for Aging and Population Health, Pittsburgh, Pennsylvania.
Francis VerbekeDepartment of Nephrology, Ghent University Hospital, Ghent, Belgium.
Kang-Ling WangSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
David J WebbUniversity/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Tine Willum HansenResearch Center for Prevention and Health, Glostrup Hospital, Glostrup and Steno Diabetes Center, Glostrup, Denmark.
Sophia ZoungasSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Carmel M McEnieryClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom.
John R CockcroftWales Heart Research Institute, Cardiff, United Kingdom.
Ian B WilkinsonClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom.
University of Bristol · GBAustralian Regenerative Medicine Institute · AUBoston University · USDélégation Paris 5 · FRNational Yang Ming Chiao Tung University · TWUniversity of Cambridge · GBCardiff Metropolitan University · GBEscola Superior de Tecnologia da Saúde de Coimbra · PTGhent University Hospital · BEGlostrup Hospital · DKGuy's Hospital · GBHiroshima University · JPNational Heart Lung and Blood Institute · USNational Institute on Aging · USNational Institutes of Health · USNorwood Hospital · USThe Queen's Medical Research Institute · GBThe University of Osaka · JPUniversity of Manchester · GB

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
Framingham: Inflammation, Genes &Cardiovascular DiseaseR01HL076784 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2004 to 2008
$3.9M
Ventricular Vascular Coupling: Correlates and PrognosisR01HL080124 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2005 to 2009
$3.4M
Biomarkers of Ventricular and Vascular RemodelingR01HL077447 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2005 to 2009
$2.6M
Vascular Function in the Framingham Third GenerationR01HL070100 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2002 to 2005
$2.4M
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham StudyR01AG028321 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2006 to 2010
$1.8M
DYNAMICS OF HEALTH .AGING . AND BODY COMPOSITION /Pittsburgh/-260962101N01AG062101 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1996 to 2004
$996k
ASYMPTOMATIC LEFT VENTRICULAR DYSFUNCTIONK24HL004334 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2001 to 2008
$707k
ENDOTHELIAL VASAMOTOR FUNCTION IN THE FRAMINGHAM STUDYR01HL060040 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 1999 to 2002
$595k
Genetics of Oxidative Stress in Ventricular RemodelingR01HL071039 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S. · 2002 to 2003
$252k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
British Heart Foundation FS/12/8/29377NHLBI NIH HHS K24 HL004334NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL060040NHLBI NIH HHS R01 HL070100NHLBI NIH HHS R01 HL071039NHLBI NIH HHS R01 HL076784NHLBI NIH HHS R01 HL077447NHLBI NIH HHS R01 HL080124NIA NIH HHS N01 AG062101NIA NIH HHS P30 AG024827NIA NIH HHS R01 AG028321
6 · The paper itself

Abstract

objectivesThe goal of this study was to determine whether aortic pulse wave velocity (aPWV) improves prediction of cardiovascular disease (CVD) events beyond conventional risk factors.

backgroundSeveral studies have shown that aPWV may be a useful risk factor for predicting CVD, but they have been underpowered to examine whether this is true for different subgroups.

methodsWe undertook a systematic review and obtained individual participant data from 16 studies. Study-specific associations of aPWV with CVD outcomes were determined using Cox proportional hazard models and random effect models to estimate pooled effects.

resultsOf 17,635 participants, a total of 1,785 (10%) had a CVD event. The pooled age- and sex-adjusted hazard ratios (HRs) per 1-SD change in loge aPWV were 1.35 (95% confidence interval [CI]: 1.22 to 1.50; p < 0.001) for coronary heart disease, 1.54 (95% CI: 1.34 to 1.78; p < 0.001) for stroke, and 1.45 (95% CI: 1.30 to 1.61; p < 0.001) for CVD. Associations stratified according to sex, diabetes, and hypertension were similar but decreased with age (1.89, 1.77, 1.36, and 1.23 for age ≤50, 51 to 60, 61 to 70, and >70 years, respectively; pinteraction <0.001). After adjusting for conventional risk factors, aPWV remained a predictor of coronary heart disease (HR: 1.23 [95% CI: 1.11 to 1.35]; p < 0.001), stroke (HR: 1.28 [95% CI: 1.16 to 1.42]; p < 0.001), and CVD events (HR: 1.30 [95% CI: 1.18 to 1.43]; p < 0.001). Reclassification indices showed that the addition of aPWV improved risk prediction (13% for 10-year CVD risk for intermediate risk) for some subgroups.

conclusionsConsideration of aPWV improves model fit and reclassifies risk for future CVD events in models that include standard risk factors. aPWV may enable better identification of high-risk populations that might benefit from more aggressive CVD risk factor management.

Indexed as

AortaCardiovascular DiseasesHumansObservational Studies as TopicPredictive Value of TestsProspective StudiesPulse Wave Analysiscardiovascular diseasemeta-analysisprognostic factorpulse wave velocity

Identifiers

PMID24239664
PMCPMC4401072
OpenAlexW2143691602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.